Biocracked
Approach 4, conceptual metaphor, in palette D, bold color field.

A single raw cacao pod, split open lengthwise, sits on a saturated mustard-yellow seamless backdrop. Beside it, a plain round multivitamin tablet balances on the edge of a clear glass lab dish. Between them, a thin laboratory balance beam is level, one pan holding cacao nibs and the other holding the tablet, to suggest an even result with no clear winner. Shot at a low three-quarter angle with a shallow depth of field. Soft, diffuse studio light from the upper left casts gentle warm-grey shadows. The cacao is deep burgundy-brown with glossy, wet-looking beans, which contrasts sharply with the yellow. One tiny electric green sticker dot on the dish rim is the only accent. The mood is calm, curious and impartial, and the image has no text.
Supplements

Multivitamin or Cocoa Flavanols for Alzheimer's Markers? The Result

Nova Chen · · 4 min read

If you've been hoping a daily multivitamin or a cocoa flavanol capsule might quietly turn down the dial on Alzheimer's-related changes in your blood, here is the news: in one of the most closely watched supplement trials in older adults, it didn't. Over two years, neither intervention measurably shifted three key neurodegeneration biomarkers. The null result is still worth understanding.

What the COSMOS biomarker analysis tested

The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) is a randomized, placebo-controlled 2 × 2 factorial trial. Older US adults were assigned to a multivitamin-multimineral (MVM), a cocoa extract (CE), both, or neither. The participants were free of major cardiovascular disease and recently diagnosed cancer.

  • Multivitamin: Centrum Silver
  • Cocoa extract: 500 mg/day, including 80 mg of (-)-epicatechin

This ancillary analysis, in the Journal of Alzheimer's Disease from a Brigham and Women's Hospital and Harvard team, looked at COSMOS-clinic participants. It measured two-year changes in three blood-based biomarkers:

  1. Neurofilament light chain (NfL), a protein linked to nerve-fiber injury
  2. N-terminal tau fragment (NT1), a tau-related marker
  3. Oligomeric amyloid-β (oAβ), the clumping-prone form of amyloid

The analysis included 506 people with NT1 or NfL data and 498 with oAβ data.

The headline finding: nothing moved

The researchers compared yearly percentage change in each biomarker between active supplement and placebo. None of the six comparisons was statistically significant.

Multivitamin vs. placebo

Biomarker Mean difference in yearly % change 95% CI p-value
NT1 3.7% -3% to 10.8% 0.29
NfL 3.1% -1.9% to 8.3% 0.23
oAβ -8.9% -23.9% to 9% 0.31

Cocoa extract vs. placebo

Biomarker Mean difference in yearly % change 95% CI p-value
NT1 -0.7% -7.1% to 6.1% 0.83
NfL 0.5% -4.4% to 5.6% 0.85
oAβ -5.9% -21.4% to 12.6% 0.51

The authors' conclusion is plain: daily MVM or CE, compared with placebo, did not affect two-year changes in NfL, NT1, or oAβ.

How to read these numbers

The cocoa extract results for NfL and NT1 sit very close to zero, with p-values of 0.83 and 0.85. That is about as flat as a result gets.

The multivitamin estimates for NfL and NT1 were slightly positive (3.7% and 3.1%). Higher values on these markers are generally not what you'd want. But the confidence intervals comfortably include zero, so these are not evidence of harm either. They look like statistical noise.

The oAβ results lean negative for both interventions (-8.9% and -5.9%). That might tempt an optimistic reading, but the intervals are wide, spanning roughly -24% to +13%, and the p-values are 0.31 and 0.51. The trial can't tell a real small effect from chance here. Calling this a signal would overstate what the data show.

Why a null result still matters

MVM and cocoa flavanols have both been floated as possible ways to slow cognitive aging, but the biological pathways are unclear. This analysis tested one plausible route: whether the supplements change blood markers of neuronal injury, tau, or amyloid. Over two years, in this group, they didn't.

That narrows the story. If either supplement benefits cognition, as other COSMOS reports have explored, this study gives no evidence that it works by shifting these three biomarkers. The benefit, if real, may act through other mechanisms. It may also be too small or too slow to appear in a two-year window.

Practical takeaways

Dose used in the trial: The cocoa extract provided 500 mg/day of cocoa flavanols, including 80 mg of (-)-epicatechin. The multivitamin was one Centrum Silver product. The abstract doesn't specify timing, such as morning versus evening or with meals, so there is no trial-backed schedule to cite.

Who the findings apply to: Older US adults without major cardiovascular disease or recently diagnosed cancer. Results may not carry over to younger people, to people with those conditions, or to people with established Alzheimer's disease.

What not to conclude:

  • Don't take a multivitamin or cocoa extract specifically to lower NfL, tau, or amyloid. This trial found no such effect.
  • Don't treat the result as proof that these supplements do nothing for brain health. The study measured three blood markers over two years, not clinical dementia or the full range of cognitive outcomes.
  • Don't expect a different outcome from higher doses. This trial didn't test them.

Limitations and context

  • Duration: Two years is short for processes that unfold over decades.
  • Precision: The wide confidence intervals, especially for oAβ, leave room for modest effects in either direction.
  • Surrogate endpoints: Blood biomarkers are informative but are not the same as preserving memory or preventing dementia.
  • Funding and disclosures: The authors report that COSMOS received supplement and packaging donations and infrastructure support from Mars Edge and from Pfizer Consumer Healthcare (now Haleon). Some investigators also disclosed other industry grants and honoraria. The trial's null findings run against any commercial incentive, which, if anything, adds to their credibility.

The bottom line

In a randomized trial of roughly 500 older adults, a daily multivitamin or 500 mg/day of cocoa extract flavanols did not significantly change two-year trajectories of NfL, NT1, or oligomeric amyloid-β. These supplements may have other uses, but changing Alzheimer's-related blood biomarkers is not supported by this trial.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

**Approach: Conceptual metaphor. Palette: D, bold color field.**

A single analog wall clock with a blank white face and plain black hands, photographed straight-on against a saturated mustard-yellow backdrop. Its glass is slightly fogged. Several translucent multivitamin tablets, in the speckled orange-tan of a real multivitamin, rest on the clock's lower rim and in front of its face. One tablet is half-dissolved and leaves a faint haze on the glass. The clock hands sit just short of each other, hinting that the time barely shifted. Behind the clock a thin ghost shadow of a second clock hand falls a few degrees off, suggesting a nudge that isn't conclusive. A hair-thin electric green (#00e676) second hand adds a small accent. Soft, diffused studio light from the upper left creates gentle shadows on the yellow. The camera is at eye level with a shallow depth of field. The mood is wry and skeptical, curious but unconvinced.
longevity

A Cheap Multivitamin Nudged DHA Up—But the Aging Clocks Stayed Put

BY DR. SYNAPSE ·

Two years of a daily Centrum Silver gave older adults small bumps in DHA and omega-3 fatty acids and slowed the usual rise in creatinine, according to a COSMOS randomized trial analysis. Metabolomic risk scores for 16 chronic diseases also dipped, and all seven aging clocks trended 0.5 to 1.05 years younger. The twist is that none of it survived multiple-testing correction. Here is what the data show, what they don't, and who might care.

Approach 4, conceptual metaphor, in palette D, bold color field.

A single translucent green tea leaf, its veins backlit, lies on a saturated magenta seamless backdrop beside a small pomegranate rind fragment. Together they form a split, two-part chain: a bright brass chain link made of two interlocking rings, one ring dark amber and one pale green, rests on top. Behind it, one ring has a hairline crack. Shot from a low three-quarter angle with a shallow depth of field, the front link razor sharp and the background softly blurred. Lighting is a crisp, hard key light from the upper left with a soft magenta bounce and a long defined shadow across the surface. The palette is vivid magenta, deep amber, and a small accent of electric green (#00e676) on the leaf edge. The mood is curious and skeptical: promising but unproven, with two parts joined yet not fully tested.
longevity

Urolithin A + Green Tea EGCG in Alzheimer's Mice: The Catch

BY NOVA CHEN ·

Two natural compounds, urolithin A and green tea's EGCG, were given together to Alzheimer's-model mice, and the animals' mitochondria looked markedly different afterward. Treated mice showed shifts in fission and fusion genes, higher mitophagy-associated markers, longer mitochondria and more ATP. The combination often outperformed the regimen without EGCG across mitochondrial and neuronal measures. But this was injected dosing in mice, and the authors say mitophagic flux, respiration and EGCG's specific role still need testing. Here's what the study found, what it can't tell us, and why it isn't a supplement recommendation.

Approach: Conceptual metaphor, in a bold color field palette (D).

A single glass beaker half-filled with a clear, faintly amber ketone drink sits on a glossy saturated teal surface against a matching teal backdrop. Two small, realistic grey-white laboratory mice, one slightly larger and leaner, one smaller and alert, perch on either side of the beaker. In front of the female mouse is a tiny wooden maze of simple straight walls, and in front of the male is a small steel scale. The camera is at a low three-quarter angle, 85mm lens, shallow depth of field, with the beaker sharp. Soft, large-source studio light from the upper left throws gentle warm shadows, and the amber liquid glows with a thin rim of electric green light along the glass edge. Mood: curious, precise, quietly optimistic. No text.
longevity

Ketone Drink Helped Old Female Mice Remember, Males Lose Fat

BY NOVA CHEN ·

Old mice given a ketone ester diet got very different payoffs depending on sex. Males ended up with less body fat and more relative lean mass, while females made fewer errors on a memory maze and showed lower hippocampal IL-1β. Both sexes saw higher β-hydroxybutyrate and lower glucose after eating. But this is aged-mouse research, and nobody knows yet whether humans would respond the same way. Here is what the study found, what ketone monoesters are, and who might want to think twice.

**Approach: Conceptual metaphor. Palette: D, bold color field.**

A saturated mustard-yellow seamless backdrop. At center, a single thick braided rope, slightly frayed and with several strands unraveling, hangs from the top of the frame. Its lower end is tied around a smooth, matte-black kettlebell. Beside the rope, five whole fruits and leaves rest on the surface in a loose row: a halved purple-red grape, a cocoa pod split open, a green tea leaf, a small onion, and a curled shrimp shell. Only two of them sit close to the rope. The other three are scattered farther away, which suggests uneven results. Shot at a slight low three-quarter angle with a 50mm lens. Hard, directional studio light from the upper left casts crisp, defined shadows on the yellow. A tiny electric green leaf tip is the only green accent. The mood is skeptical, sharp and editorial.
longevity

Do Polyphenol Supplements Rebuild Muscle After 55? Not So Fast

BY DR. SYNAPSE ·

Quercetin, green tea catechins, cocoa flavonoids, epicatechin, and marine polyphenols all sound like ideal tools against age-related muscle loss. A new GeroScience systematic review pulled together the randomized trials in adults 55 and older, and the picture is far less tidy than the marketing. Strength improved between groups in just two of five completed trials, and muscle mass results were inconsistent and often confounded by exercise and amino acids. Here is what was tested, what the evidence can and cannot say, and who should keep an eye on the next wave of research.

This page is available in